• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长春瑞滨神经毒性:23例患者的临床和神经生理学发现

Vinorelbine neurotoxicity: clinical and neurophysiological findings in 23 patients.

作者信息

Pace A, Bove L, Nisticò C, Ranuzzi M, Innocenti P, Pietrangeli A, Terzoli E, Jandolo B

机构信息

Neurology Service, Regina Elena National Cancer Institute, Rome, Italy.

出版信息

J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):409-11. doi: 10.1136/jnnp.61.4.409.

DOI:10.1136/jnnp.61.4.409
PMID:8890782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC486585/
Abstract

Vinorelbine (5'-noranhydrovinblastine) is a new semisynthetic antineoplastic vinca alkaloid which interfers with axonal transport, inducing spiralisation of axonal microtubules and resulting in peripheral neurotoxicity. A prospective detailed neurological and electrophysiological evaluation was performed in 23 patients treated with 25 mg vinorelbine a week. All patients developed a sensory-motor distal symmetric axonal neuropathy. The neurotoxicity increased with cumulative vinorelbine doses and peripheral neuropathy was mild or moderate in most patients. After discontinuation of vinorelbine treatment, neuropathic signs and symptoms were partially reversible.

摘要

长春瑞滨(5'-去甲脱水长春碱)是一种新型半合成抗肿瘤长春花生物碱,它干扰轴突运输,诱导轴突微管螺旋化,导致周围神经毒性。对23例每周接受25mg长春瑞滨治疗的患者进行了前瞻性详细的神经学和电生理学评估。所有患者均出现感觉运动性远端对称性轴索性神经病变。神经毒性随长春瑞滨累积剂量增加,大多数患者的周围神经病变为轻度或中度。停用长春瑞滨治疗后,神经病变的体征和症状部分可逆。

相似文献

1
Vinorelbine neurotoxicity: clinical and neurophysiological findings in 23 patients.长春瑞滨神经毒性:23例患者的临床和神经生理学发现
J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):409-11. doi: 10.1136/jnnp.61.4.409.
2
A phase II, multicentre, UK study of vinorelbine in advanced breast cancer.一项关于长春瑞滨治疗晚期乳腺癌的英国多中心II期研究。
Br J Cancer. 1994 Nov;70(5):990-3. doi: 10.1038/bjc.1994.435.
3
Vinorelbine: a novel vinca alkaloid.长春瑞滨:一种新型长春花生物碱。
Am J Health Syst Pharm. 1995 Jun 15;52(12):1287-304; quizz 1340-1. doi: 10.1093/ajhp/52.12.1287.
4
Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.长春瑞滨。其药理特性及在癌症化疗中的临床应用综述。
Drugs Aging. 1994 Sep;5(3):200-34. doi: 10.2165/00002512-199405030-00006.
5
The current and future place of vinorelbine in cancer therapy.长春瑞滨在癌症治疗中的当前及未来地位。
Drugs. 1992;44 Suppl 4:36-45; discussion 66-9. doi: 10.2165/00003495-199200444-00005.
6
Vinorelbine (Navelbine). A new semisynthetic vinca alkaloid.
Onkologie. 1991 Feb;14(1):7-12. doi: 10.1159/000216938.
7
Vinorelbine as single agent in pretreated patients with advanced breast cancer.
Tumori. 1994 Aug 31;80(4):280-2. doi: 10.1177/030089169408000407.
8
A review of the antitumour activity of vinorelbine in breast cancer.
Drugs. 1992;44 Suppl 4:29-35; discussion 66-9. doi: 10.2165/00003495-199200444-00004.
9
Vinorelbine in breast cancer.长春瑞滨用于乳腺癌治疗
Expert Opin Pharmacother. 2008 Nov;9(16):2901-10. doi: 10.1517/14656566.9.16.2901.
10
Vinorelbine after paclitaxel in breast cancer: cross resistance and cumulative neurotoxicity?
Ann Oncol. 1994 May;5(5):473-4. doi: 10.1093/oxfordjournals.annonc.a058886.

引用本文的文献

1
N-imidazopyridine derivatives of noscapine as potent tubulin-binding anticancer agents: chemical synthesis and cellular evaluation.那可丁的 N-咪唑并吡啶衍生物作为有效的微管蛋白结合抗癌剂:化学合成与细胞评估
J Comput Aided Mol Des. 2025 Jun 25;39(1):36. doi: 10.1007/s10822-025-00617-0.
2
Comparing stem cell mobilization with chemotherapy and cytokine (G-CSF) versus cytokine alone in myeloma patients (MOCCCA): a randomized phase II, open-label, non-inferiority trial.骨髓瘤患者干细胞动员采用化疗联合细胞因子(粒细胞集落刺激因子)与单纯使用细胞因子的比较研究(MOCCCA):一项随机II期、开放标签、非劣效性试验
Bone Marrow Transplant. 2025 Mar;60(3):270-276. doi: 10.1038/s41409-024-02468-z. Epub 2024 Nov 15.
3
Vinorelbine causes a neuropathic pain-like state in mice via STING and MNK1 signaling associated with type I interferon induction.长春瑞滨通过与I型干扰素诱导相关的STING和MNK1信号通路,在小鼠中引发一种神经性疼痛样状态。
iScience. 2024 Jan 8;27(2):108808. doi: 10.1016/j.isci.2024.108808. eCollection 2024 Feb 16.
4
Axonal Transport Impairment in Chemotherapy-Induced Peripheral Neuropathy.化疗诱导的周围神经病变中的轴突运输障碍
Toxics. 2015 Aug 7;3(3):322-341. doi: 10.3390/toxics3030322.
5
The double-edged sword: Neurotoxicity of chemotherapy.双刃剑:化疗的神经毒性
Blood Rev. 2015 Mar;29(2):93-100. doi: 10.1016/j.blre.2014.09.012. Epub 2014 Sep 28.
6
Burden of chemotherapy-induced neuropathy--a cross-sectional study.化疗所致周围神经病的负担——一项横断面研究。
Support Care Cancer. 2011 Dec;19(12):1991-6. doi: 10.1007/s00520-010-1043-2. Epub 2010 Nov 16.
7
Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability.艾立布林结合于微管末端 tubulin 的单一结合点来抑制微管动力学不稳定性。
Biochemistry. 2010 Feb 16;49(6):1331-7. doi: 10.1021/bi901810u.
8
Vinorelbine-associated myelopathy in a patient who previously received paclitaxel: a case report.
Med Oncol. 2001;18(1):95-7. doi: 10.1385/MO:18:1:95.
9
Neurologic Complications of Cancer Therapy.癌症治疗的神经并发症
Curr Treat Options Neurol. 1999 Nov;1(5):428-437. doi: 10.1007/s11940-996-0006-x.

本文引用的文献

1
The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro.神经生长因子、睫状神经营养因子及促肾上腺皮质激素类似物对顺铂体外神经毒性的影响
Neurology. 1994 Mar;44(3 Pt 1):488-94. doi: 10.1212/wnl.44.3_part_1.488.
2
Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.长春瑞滨对经预处理的晚期乳腺癌患者是一种有效的抗增殖药物:一项II期研究。
J Clin Oncol. 1994 Oct;12(10):2094-101. doi: 10.1200/JCO.1994.12.10.2094.
3
Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies.紫杉醇和顺铂联合化疗所致周围神经病变:临床与电生理研究
Ann Neurol. 1994 Mar;35(3):304-11. doi: 10.1002/ana.410350310.
4
Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry.与腓肠神经形态测量学相关的人类糖尿病性神经内膜山梨醇、果糖和肌醇。
Ann Neurol. 1980 Dec;8(6):590-6. doi: 10.1002/ana.410080608.
5
Toxicity and response criteria of the Eastern Cooperative Oncology Group.东部肿瘤协作组的毒性及反应标准。
Am J Clin Oncol. 1982 Dec;5(6):649-55.
6
Sympathetic skin response--a method of assessing unmyelinated axon dysfunction in peripheral neuropathies.交感神经皮肤反应——一种评估周围神经病变中无髓鞘轴突功能障碍的方法。
J Neurol Neurosurg Psychiatry. 1984 May;47(5):536-42. doi: 10.1136/jnnp.47.5.536.
7
The current and future place of vinorelbine in cancer therapy.长春瑞滨在癌症治疗中的当前及未来地位。
Drugs. 1992;44 Suppl 4:36-45; discussion 66-9. doi: 10.2165/00003495-199200444-00005.
8
Preclinical and clinical pharmacology of vinca alkaloids.长春花生物碱的临床前及临床药理学
Drugs. 1992;44 Suppl 4:1-16; discussion 66-9. doi: 10.2165/00003495-199200444-00002.
9
Toxic neuropathies.
Neurology. 1979 Apr;29(4):429-31. doi: 10.1212/wnl.29.4.429.